Iron Triangle Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$52.5M Buy
320,474
+50,474
+19% +$7.91M 6% 3
2025
Q3
$36.1M Buy
+270,000
New +$32.8M 5.13% 8
2024
Q1
Sell
-82,537
Closed -$14.8M 36
2023
Q4
$14.8M Buy
+82,537
New +$12.8M 1.92% 23
2023
Q1
Sell
-178,000
Closed -$30.1M 33
2022
Q4
$30.1M Buy
178,000
+78,000
+78% +$14.1M 5.4% 8
2022
Q3
$18.7M Sell
100,000
-150,000
-60% -$31.6M 3.27% 12
2022
Q2
$40.6M Buy
+250,000
New +$39.5M 5.26% 4
2020
Q1
Sell
-150,000
Closed -$13.9M 32
2019
Q4
$13.9M Buy
+150,000
New +$12.6M 3.68% 12

Other funds holding RGEN

Iron Triangle Partners's RGEN Position: Q4 2025 in Review

Iron Triangle Partners increased its Repligen (RGEN) stake by 19% in Q4 2025, buying an estimated $7.91M and bringing the position to 320,474 shares worth $52.5M. The position accounts for 6% of the portfolio, ranked #3.

Iron Triangle Partners first reported a position in RGEN in Q4 2019 and has held it in 7 quarters since. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Iron Triangle Partners held 320,474 shares of Repligen worth $52.5M as of Q4 2025.
  • Iron Triangle Partners bought 50,474 Repligen shares in Q4 2025, an estimated $7.91M.
  • Repligen made up 6% of Iron Triangle Partners's portfolio in Q4 2025, its #3 holding.
  • Iron Triangle Partners first reported a position in Repligen in Q4 2019 and has held it in 7 quarters since.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.